Polymeric Approach to Adjuvant System in Antibody Production against Leishmaniasis Based on Hybridoma Technology

1. Roque AL, Jansen AM. Wild and synan-thropic reservoirs of Leishmania species in the Americas. Int J Parasitol Parasites Wildl. 2014; 3:251-262.
2. Ertug S, Gultekin B, Doyuran ES. 2001 Yılında Aydın İl Sağlık Müdürlüğü'ne İhbar Edilen İç Organ ve Deri Leishmaniasis Olguları. ADÜ Tıp Fakultesi Dergisi. 2002; 3:9–12.
3. Handemir E, Oncel T, Kamburgil K. Is-tanbul Sokak Kopeklerinde Visseral Leishmaniasis Seroprevalansı. Turkiye Parazitol Derg. 2004; 28:123-125.
4. Organization WH. Expert Committee on the Control of Leishmaniases. In: Tech-nical Report Series 2010; 949.
5. Serin SM, Dağlıoğlu K, Bağırova M, et al. Rapid diagnosis and genotyping of Leish-mania isolates from cutaneous and visceral Leishmaniasis by microcapillary cultivation and polymerase chain reaction-restriction fragment length polymorphism of mini exon region. Diagn Microbiol Infect Dis. 2005; 53:209-214.
6. Ozbilgin A, Harman M, Karakus M, et al. Leishmaniasis in Turkey: Visceral and cu-taneous leishmaniasis caused by Leishmania donovani in Turkey. Acta Trop. 2017; 173: 90-96.
7. Allahverdiyev AM, Uzun S, Bağırova M, Durdu M, Memişoğlu HR. A sensitive new microculture method for diagnosis of cu-taneous leishmaniasis. Am J Tro Med Hyg. 2004; 70: 294-297.
8. Harith AE, Kolk AH J, Kager PA, et al. Evaluation of a newly developed direct ag-glutination test (DAT) for serodiagnosis and sero-epidemiological studies of viscer-al leishmaniasis: comparison with IFAT and ELISA. Trans R Soc Trop Med Hyg. 1987; 81(4), 603-606.
9. Ashford DA, Badaro R, Eulalio C, et al. Studies on the control of visceral leish-maniasis: validation of the Falcon assay screening test-enzyme-linked immuno-sorbent assay (FAST-ELISA™) for field diagnosis of canine visceral leishmaniasis. Am J Trop Med Hyg. 1993; 48(1):1-8.
10. Ozensoy S, Ozbel Y, Turgay N, et al. Se-rodiagnosis and epidemiology of visceral leishmaniasis in Turkey. Am J Trop Med Hyg. 1998; 59(3): 363-369.
11. El Safi SH, Evans DA. A comparison of the direct agglutination test and enzyme-linked immunosorbent assay in the sero-diagnosis of Leishmaniasis in the Sudan. Trans R Soc Trop Med Hyg. 1989; 83: 334-337.
12. Miller J. “The thymus in immunity”. Princ Med Biol. 1996; 6: 1-20.
13. Mathur P, Samantaray JC. The first proba-ble case of platelet transfusion-transmitted visceral leishmaniasis. Transfus Med. 2004; 14(4), 319–321.
14. Khabiri AR, Bagheri F, Naddaf SR, Ass-mar M, Taghavi AH. Characterization of a Monoclonal Antibody Specific for the Par-asite Surface Antigen-2 of Leishmania major. Iran J Public Health. 2004; 10-14.
15. Fong D, Chang KP. Surface antigenic change during differentiation of a parasitic protozoan, Leishmania mexicana: Identifica-tion by monoclonal antibodies. Proc Natl Acad Sci U S A. 1982; 79(23): 7366-7370.
16. Handman E, Hocking RE. Stage-specific, strain-specific, and cross-reactive antigens of Leishmania species identified by mono-clonal antibodies. Infect Immun. 1982; 37(1), 28-33.
17. Nejad-Moghaddam A, Abolhassani M. Epitope mapping of a common 57 kDa antigen of Leishmania species by monoclo-nal antibodies. Vaccine. 2010; 28(37), 6036-6040.
18. Nejad-Moghaddam A, Abolhassani M. Production and characterization of mono-clonal antibodies recognizing a common 57-kDa antigen of Leishmania species. Iran Biomed J. 2009; 13(4): 245-251.
19. Aguilar JC, Rodriguez EG. Vaccine adju-vants revisited. Vaccine. 2007; 25: 3752-3762.
20. Nouri A, Mohamed FAN, Laraba-Djebari F. New and safe formulation for scorpion immunotherapy: Comparative study be-tween saponin and FCA adjuvants associ-ated to attenuated venom. Vaccine. 2018; 36(13): 1720-1727.
21. Oscherwitz J, Hankenson FC, Yu F, Cease KB. Low-dose intraperitoneal Freund's ad-juvant: Toxicity and immunogenicity in mice using an immunogen targeting amy-loid-β peptide. Vaccine. 2006; 24(15): 3018-3025.
22. Dyakonova VA, Dambaeva SV, Pinegin BV, Khaitov RM. Study of interaction be-tween the polyoxidonium immunomodu-lator and the human immune system cells. Int. Immunopharmacol. 2004; 4(13):1615-1623.
23. Toptygina A, Semikina E, Alioshkin V. Influence of an immunopotentiator poly-oxidonium on cytokine profile and anti-body production in children vaccinated with Priorix. Arch Physiol Biochem. 2012; 118(4): 197-203.
24. Aydogdu M, Bagirova M, Allahverdiyev A, et al. Large-scale cultivation of Leishmania infantum promastigotes in stirred bioreac-tor. J Vector Borne Dis. 2019;56(4):345-350.
25. Tosyali OA, Allahverdiyev A, Bagirova M, et al. Nano-co-delivery of lipophosphogly-can with soluble and autoclaved Leishmania antigens into PLGA nanoparticles: Evalua-tion of in vitro and in vivo immunostimu-latory effects against visceral leishmaniasis. Mater Sci Eng C Mater Biol Appl. 2021; 120:111684.
26. Ethan A, Lerner BA. How to Make a Hy-bridoma. Yale J Biol Med. 1981; 54: 387-402.
27. Sereda AD, Makarov VV, Sachivkina NP, et al. Effectiveness of combined use: inac-tivated vaccines with immunostimulants on the in vivo model of teschen disease. Adv Anim Vet Sci. 2020; ISSN (Online) 2307-8316; ISSN (Print) 2309-3331.
28. Nourizadeh E, Zargar SJ, Alimohammadi-an MH, Ajdary S, Mahdavi M. Develop-ment of monoclonal antibodies against axenic amastigotes of Leishmania infantum strain in Iran: implication for diagnosis of Kala-azar. Iran J Basic Med Sci. 2018; 21(4):388.
29. El Roufaie Mohammed EA, Wright E, Kager PA, Laarman J, Pondman K. ELI-SA using intact promastigotes for immu-nodiagnosis of kala-azar. Trans R Soc Trop Med Hyg. 1985; 79: 344-350.
30. Allahverdiyev AM, Koc RC, Bagirova M, et al. A new approach for development of vaccine against visceral leishmaniasis: Lip-ophosphoglycan and polyacrylic acid con-jugates. Asian Pac J Trop Med. 2017; 10(9):877-886.
31. Topuzogullari M, Cakir Koc R, Dincer Isoglu S, et al. Conjugation, characteriza-tion and toxicity of lipophosphoglycan-polyacrylic acid conjugate for vaccination against leishmaniasis. J Biomed Sci. 2013; 3;20(1):35
32. Herwaldt BL. Leishmaniasis. Lancet. 1999; 354:1191-1199.
33. Rezaei Z, Van Reet N, Pouladfar G, et al. Expression of a rK39 homologue from an Iranian Leishmania infantum isolate in Leish-mania tarentolae for serodiagnosis of visceral leishmaniasis. Parasit Vectors. 2019; 18;12(1):593.
34. Sanchez MCA, Celeste BJ, Lindoso JAL, et al. Performance of rK39-based immu-nochromatographic rapid diagnostic test for serodiagnosis of visceral leishmaniasis using whole blood, serum and oral fluid. PLoS One. 2020; 15(4):e0230610.
35. Paul WE. The Immune System: An Intro-duction, Fundamental Immunology. 7th Ed 2013.
36. Delves PJ, Martin SJ, Burton DR, Roitt IM. Roitt's essential immunology. Wiley-Blackwell. 2011.
37. Janeway CA, Travers P, Walport M, Shlomchik M. Immunobiology: The Im-mune System in Health & Disease. 2005.
38. Freund J. The mode of action of immuno-logical adjuvants. Adv Tuberc Res. 1956; 7:130–148.
39. Basu P, Saha N, Saha T, Saha P. Polymeric hydrogel based systems for vaccine deliv-ery: A review. Polymer. 2021; Volume 230, 124088.
40. W. Jianga, R.K. Gupta, M.C. Deshpande, S.P. Schwendeman. Biodegradable poly (lactic-co-glycolic acid) microparticles for injectable delivery of vaccine antigens. Adv Drug Deliv Rev. 57. 2005; 391–410.

留言 (0)

沒有登入
gif